Skip to main content
Fig. 2 | BMC Pharmacology and Toxicology

Fig. 2

From: Real life evaluation of the multi-organ effects of Lumacaftor/Ivacaftor on F508del homozygous cystic fibrosis patients

Fig. 2

Bone metabolism parameters through 12 months of LUM-IVA treatment. Single subject and mean (blue solid) curves are presented for A Alkaline-Phosphatase (U/L), B Calcium (mg/dL), C CA/CR urine, D PTH (pg/mL), E Phosphor (mg/dL), F Vitamin D (nmol/L), X axis represents the study visits in months (M). Y axis represents a scale of the value of each tested parameter.

Back to article page